Planning and Evaluation Committee

Chair Yolanda N. Mageto, MD, MPH, ATSF Dallas, TX
Vice Chair J. Daryl Thornton, MD, MPH, ATSF Cleveland, OH
Committee Member Bartolome R. Celli, MD Wellesley, MA
Committee Member C. Terri Hough, MD, MSc, ATSF Portland, OR
Committee Member Jeremy B. Richards, MD, MA, ATSF, FACP Cambridge, MA
Committee Member Jess Mandel, MD, ATSF La Jolla, CA
Committee Member Linda L. Chlan, PhD, RN, ATSF Rochester, MN
Committee Member Lori Sakoda, PhD, MPH Oakland, CA
Committee Member Mark S. Forshag, MD, MHA New Orleans, LA
Committee Member Melanie Koenigshoff, MD, PhD, ATSF Pittsburgh, PA
Committee Member - PAR Representative Michele Manion, BS Minneapolis, MN
Committee Member - Emeritus Molly L. Osborne, MD, PhD, ATSF Portland, OR
Committee Member Paul E. Moore, MD, ATSF Nashville, TN
Committee Member Polly E. Parsons, MD, ATSF Williston, VT
Committee Member Rachel Thomson, MBBS, PhD, FRACP GREENSLOPES, QUEENSLAND, Australia
Committee Member Raed A. Dweik, MD, ATSF Cleveland, OH
Committee Member Richard A. Johnston, PhD, ATSF Morgantown, WV
Committee Member Shalini Manchanda, MBBS Indianapolis, IN
Committee Member Sushma K. Cribbs, MD, MSCR, ATSF Decatur, GA
Staff Karen J. Collishaw New York, NY
Staff Cristina Braz New York, NY
Staff Stephen Altobelli New York, NY

The primary purpose of the planning and evaluation committee is to identify emerging trends and challenges that affect the ability of ATS to accomplish its missions, and to provide advice and recommendations regarding ATS policy and service. The Committee periodically evaluates the effectiveness of the Society in accomplishing its mission and goals and in serving its members and the public by reviewing Society activities and accomplishments in specific areas. In conjunction with the Executive Committee, it also chooses specific areas for evaluation.

Benchmarks, 2022-2023:
• Revisit the Committee’s February 2020 recommendations for Data Dashboards and Visioning process and incorporate additional considerations based on permanent changes due to the COVID-19 pandemic. Finalize and present measures of success in improving the functioning and communications among assemblies and committees over the next 5 years.
• Evaluate the recommendations from the 2019-2020 International Member Value Task Force and collaborate with the International Health and Membership Committees on the prioritization and implementation of these activities. Development metrics to evaluate these initiatives on an ongoing basis.
• Evaluate the Society’s response to the COVID-19 pandemic. Identify and prioritize new metrics, best practices and processes needed as a result. Develop common tracking metrics for post-COVID trends and integrate them into current and planned reports.
• Finalize cycle to review and evaluate proposed new Special Interest Groups. Triage long-standing Special Interest Groups to relevant areas of the Society for permanent oversight. Develop standardized metrics for every Interest Group.
• Evaluate the impact of COVID-related burnout on the workforce in the ATS membership, with particular emphasis on the mid-career demographic. Identify metrics to define and track these effects on the Society’s program content, topics of interest, and attendance.
• In collaboration with the Members in Transition and Training Committee, Training Committee and the Membership Committee, evaluate the Society’s opportunities for early and mid-career professionals to better understand their educational and career needs. Conduct a gap analysis of the available programs and recommend any needed adjustments and proposed outcomes.
• In collaboration with the Health Equity and Diversity Committee (HEDC), support the implementation of priority strategies from the HEDC Road Map of initiatives and purpose metrics for evaluation and benchmarks of success for these activities.
• Nominate a diverse slate of candidates for ATS Respiratory Health Awards.